Concepedia

Tobias Bexte

TB

6

Publications

302

Citations

6

H-Index

2020

Active since

Affiliations

Goethe University Frankfurt(Current)

Frankfurt Cancer Institute

University Hospital Frankfurt

Deutschen Konsortium für Translationale Krebsforschung

University of Freiburg

Tobias Bexte is an author at Goethe University Frankfurt specializing in medicine, cell biology, and immunotherapy.

ORCID

Top concepts

Publications per year

2020–2024

6

Publications

6

High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia

Stephan Müller, Tobias Bexte, Veronika Gebel et al. · Frontiers in Immunology · 2020 · 106 citations · Full text

, , +11

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Tobias Bexte, Jamal Alzubi, Lisa Marie Reindl et al. · OncoImmunology · 2022 · 74 citations · Full text

CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells

Tobias Bexte, Nawid Albinger, Ahmad Al Ajami et al. · Nature Communications · 2024 · 54 citations · Full text

, , +7

Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors

Tobias Bexte, Lacramioara Botezatu, Csaba Miskey et al. · Molecular Therapy · 2024 · 35 citations · Full text

, , +9

CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML

Nawid Albinger, Tobias Bexte, Leon Buchinger et al. · Blood · 2022 · 21 citations

Rows per page

1–5 of 6